Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease on Hemodialysis
Clinical trial NCT01785849 · COMPLETED
Trial details
- NCT number
- NCT01785849
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-12
- Primary completion
- 2014-05-22
- Enrollment
- 508
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.